TABLE 1.
Characteristics of cisplatin subjects (n = 24)
| Gender | |
| Male | 22 (91.7%) |
| Female | 2 (8.3%) |
| Ethnicity | |
| Non-Hispanic white | 15 (62.5%) |
| American Indian/Alaskan | 1 (4.2%) |
| Hispanic | 0 (0.0%) |
| African American | 1 (4.2%) |
| Other | 7 (29.2%) |
| Age (mean, range) | 58.5 (28–75) |
| Number of follow-up tests (mean, range) | 3.4 (1–9) |
| Final cumulative drug dose, mg (mean, range) | 347.5 (150–600) |
| Total days exposed (mean, range) | 41.7 (1–160) |
| Total number of doses (mean, range) | 3.3 (1–14) |
| Number of subjects with no hearing change | 12 |
| Number of subjects with unilateral hearing change | 8 |
| Number of subjects with bilateral hearing change | 4 |